Home News Research Nutriventia Proclaims Publication of Revolutionary TurmXTRA60N Research Showing Substantial Joint Health Benefits

Nutriventia Proclaims Publication of Revolutionary TurmXTRA60N Research Showing Substantial Joint Health Benefits

The Mumbai-based Nutriventia brand from Inventia Healthcare Ltd. recently announced new research on its unique turmeric branded ingredient. The investigation was published in Clinical Pharmacology: Advances and Application Journal. The study indicates the benefits of TurmXtra60N at small doses of 250mg for healthy people experiencing knee pains after a workout. “This study is pivotal as it showcases the benefits of a small dose of TurmXTRA60N in healthy subjects. The supplement helps preserve knee structure and function,” explained Anand Godbole, Inventia Assistant Vice-president of marketing and strategy.

The 90-day, randomized, double-blind, placebo-controlled clinical trial was done on 96 healthy adults who felt knee pain after physical exertion. The findings indicated significant improvements in joint comfort, mobility, and performance post physical exertion. The clinically relevant improvement in efficacy was reported as early as day 45. Measurement was done on several test parameters that evaluated several aspects of joint mobility and the perception of pain. 

The research is the final part of a comprehensive clinical package that evolved from a preclinical study that established ten times higher bioavailability when compared to standard turmeric extracts of equal dose format and pharmacokinetic study in healthy human subjects. Bioequivalence of a 250mg dose of TurmXTRA60N to 1575mg standard turmeric extract with 95% curcuminoids was established.

The Nutriventia brand foundation is underlined in four major cornerstones; innovation, transparency, talent naturing, and a holistic responsibility and accountability to people and the environment. The company’s purpose is best defined by its corporate philosophy on providing enhanced ingredients with better usability and clinically substantiated therapeutic benefits to consumers.

- Advertisment -

Most Popular

GC Rieber VivoMega Launches Sampling Program Ahead of SupplySide West

GC Rieber VivoMega, a leading global supplier of high-quality omega-3 concentrates, has announced the unveiling of its VivoMega softgel sampling program. Targeted...

PBG BioPharma Inc. Acquires GMP Manufacturing Site License

PBG BioPharma Inc., (PBG), a phytochemical biopharmaceutical group, has announced its receipt of a manufacturing site license issued by the Natural and...

CII Continues to Produce Consistent High-Quality Food Particulates

The Cereals Ingredients, Inc. (CII) is a privately held, employee-owned specialty ingredients manufacturer established to deliver food innovations. The company was formed...
Read more

ASR Group Unveils Powder Distillates that Modulate Bitterness and Enhance Sweetness, Helping Manufacturers Achieve Cleaner Label Status

Sugar Cane Distillate is produced through the distillation of leaves and stalks of selected sugarcane varieties. ASR Group’s new powdered distillates are...

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisment -